Exhibit 5.1

Our ref: VSL/759352-000001/15429152v3
AnPacBio-Medical Science Co., Ltd.
801 Bixing Street, Bihu County
Lishui, Zhejiang Province, 323006
People’s Republic of China
31 October 2019
AnPacBio-Medical Science Co., Ltd. (the “Company”)
We have acted as counsel as to British Virgin Islands law to the Company in connection with the Company’s registration statement on FormF-1, including all amendments or supplements thereto (the “Registration Statement”), filed with the Securities and Exchange Commission under the U.S. Securities Act of 1933, as amended to date relating to the offering by the Company (the “Offering”) of certain American depositary shares (the “ADSs”) representing the Company’s Class A Ordinary Shares of a par value of US$0.01 each of the Company (the “Shares”).
We are furnishing this opinion as Exhibits 5.1, 8.1 and 23.2 to the Registration Statement.
We have reviewed originals, copies, drafts or conformed copies of the following documents:
1.1 | The public records of the Company on file and available for public inspection at the Registry of Corporate Affairs in the British Virgin Islands (the “Registry of Corporate Affairs”) on 30 October 2019, including the Company’s Certificate of Incorporation and its Amended and Restated Memorandum and Articles of Association (the “Memorandum and Articles”). |
1.2 | The Second Amended and Restated Memorandum and Articles of Association of the Company (the “Second Amended and Restated Memorandum and Articles of Association”) as adopted by the shareholders of the Company on 29 October 2019 and effective from registration of the same by the Registry of Corporate Affairs and the Third Amended and Restated Memorandum and Articles of Association of the Company (the “Third Amended and Restated Memorandum and Articles of Association”) as adopted by the shareholders of the Company on 31 October 2019 and effective from registration of the same by the Registry of Corporate Affairs. |